Cargando…
Circulating levels of irisin in middle-aged first-degree relatives of type 2 diabetes mellitus — correlation with pancreatic β-cell function
BACKGROUND: Irisin is a novel myokine secreted in response to peroxisome proliferator-activated receptor γ coactivator-1α (PGC-1α) activation through exercise. The first-degree relatives (FDRs) of type 2 diabetes mellitus (T2DM) patients bear a lifetime risk for developing T2DM, especially after 40...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4271516/ https://www.ncbi.nlm.nih.gov/pubmed/25530809 http://dx.doi.org/10.1186/1758-5996-6-133 |
_version_ | 1782349621420359680 |
---|---|
author | Yang, Meili Chen, Peihong Jin, Hua Xie, Xinmiao Gao, Ting Yang, Lili Yu, Xuemei |
author_facet | Yang, Meili Chen, Peihong Jin, Hua Xie, Xinmiao Gao, Ting Yang, Lili Yu, Xuemei |
author_sort | Yang, Meili |
collection | PubMed |
description | BACKGROUND: Irisin is a novel myokine secreted in response to peroxisome proliferator-activated receptor γ coactivator-1α (PGC-1α) activation through exercise. The first-degree relatives (FDRs) of type 2 diabetes mellitus (T2DM) patients bear a lifetime risk for developing T2DM, especially after 40 years old. However, the circulating irisin levels in middle-aged FDRs of T2DM is unclear. We therefore investigated the association between circulating irisin and pancreatic β-cell function in normal-glucose-tolerance (NGT) subjects. METHODS: In this cross-sectional study, we recruited 412 supposed healthy subjects aged 40-60 who were FDRs of T2DM patients but without previous diagnosis of T2DM. Of the 412 individuals, 254 had NGT and 60 were newly diagnosed T2DM based on the results of a 75 g oral glucose tolerance test (OGTT- World Health Organization diagnostic criteria). We measured irisin in the newly diagnosed T2DM group (n = 60) and in an age- and sex-matched NGT subgroups (n = 62). Serum irisin was quantified by ELISA, and its association with metabolic parameters was analysed by Pearson’s correlation and multiple linear regression analyses. RESULTS: There was no significant difference in serum irisin between middle-aged newly diagnosed T2DM patients and the NGT control group. Circulating irisin was correlated with haemoglobin A1c (r = 0.202, p = 0.026) and estimated glomerular filtration rate (r = 0.239, p = 0.010). Multiple linear regression revealed that only homeostasis model assessment-β (HOMA-β) was associated with irisin in NGT subjects after adjusting for confounding factors. However, similar analysis in T2DM did not reveal a significant association between circulating irisin and metabolic parameters. CONCLUSIONS: There was no significant difference in serum irisin between middle-aged newly diagnosed T2DM patients and the NGT controls. Serum irisin level was closely related to HOMA-β in NGT, suggesting that irisin may play a crucial role in pancreatic β-cell function. |
format | Online Article Text |
id | pubmed-4271516 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-42715162014-12-20 Circulating levels of irisin in middle-aged first-degree relatives of type 2 diabetes mellitus — correlation with pancreatic β-cell function Yang, Meili Chen, Peihong Jin, Hua Xie, Xinmiao Gao, Ting Yang, Lili Yu, Xuemei Diabetol Metab Syndr Research BACKGROUND: Irisin is a novel myokine secreted in response to peroxisome proliferator-activated receptor γ coactivator-1α (PGC-1α) activation through exercise. The first-degree relatives (FDRs) of type 2 diabetes mellitus (T2DM) patients bear a lifetime risk for developing T2DM, especially after 40 years old. However, the circulating irisin levels in middle-aged FDRs of T2DM is unclear. We therefore investigated the association between circulating irisin and pancreatic β-cell function in normal-glucose-tolerance (NGT) subjects. METHODS: In this cross-sectional study, we recruited 412 supposed healthy subjects aged 40-60 who were FDRs of T2DM patients but without previous diagnosis of T2DM. Of the 412 individuals, 254 had NGT and 60 were newly diagnosed T2DM based on the results of a 75 g oral glucose tolerance test (OGTT- World Health Organization diagnostic criteria). We measured irisin in the newly diagnosed T2DM group (n = 60) and in an age- and sex-matched NGT subgroups (n = 62). Serum irisin was quantified by ELISA, and its association with metabolic parameters was analysed by Pearson’s correlation and multiple linear regression analyses. RESULTS: There was no significant difference in serum irisin between middle-aged newly diagnosed T2DM patients and the NGT control group. Circulating irisin was correlated with haemoglobin A1c (r = 0.202, p = 0.026) and estimated glomerular filtration rate (r = 0.239, p = 0.010). Multiple linear regression revealed that only homeostasis model assessment-β (HOMA-β) was associated with irisin in NGT subjects after adjusting for confounding factors. However, similar analysis in T2DM did not reveal a significant association between circulating irisin and metabolic parameters. CONCLUSIONS: There was no significant difference in serum irisin between middle-aged newly diagnosed T2DM patients and the NGT controls. Serum irisin level was closely related to HOMA-β in NGT, suggesting that irisin may play a crucial role in pancreatic β-cell function. BioMed Central 2014-12-05 /pmc/articles/PMC4271516/ /pubmed/25530809 http://dx.doi.org/10.1186/1758-5996-6-133 Text en © Yang et al.; licensee BioMed Central Ltd. 2014 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Yang, Meili Chen, Peihong Jin, Hua Xie, Xinmiao Gao, Ting Yang, Lili Yu, Xuemei Circulating levels of irisin in middle-aged first-degree relatives of type 2 diabetes mellitus — correlation with pancreatic β-cell function |
title | Circulating levels of irisin in middle-aged first-degree relatives of type 2 diabetes mellitus — correlation with pancreatic β-cell function |
title_full | Circulating levels of irisin in middle-aged first-degree relatives of type 2 diabetes mellitus — correlation with pancreatic β-cell function |
title_fullStr | Circulating levels of irisin in middle-aged first-degree relatives of type 2 diabetes mellitus — correlation with pancreatic β-cell function |
title_full_unstemmed | Circulating levels of irisin in middle-aged first-degree relatives of type 2 diabetes mellitus — correlation with pancreatic β-cell function |
title_short | Circulating levels of irisin in middle-aged first-degree relatives of type 2 diabetes mellitus — correlation with pancreatic β-cell function |
title_sort | circulating levels of irisin in middle-aged first-degree relatives of type 2 diabetes mellitus — correlation with pancreatic β-cell function |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4271516/ https://www.ncbi.nlm.nih.gov/pubmed/25530809 http://dx.doi.org/10.1186/1758-5996-6-133 |
work_keys_str_mv | AT yangmeili circulatinglevelsofirisininmiddleagedfirstdegreerelativesoftype2diabetesmellituscorrelationwithpancreaticbcellfunction AT chenpeihong circulatinglevelsofirisininmiddleagedfirstdegreerelativesoftype2diabetesmellituscorrelationwithpancreaticbcellfunction AT jinhua circulatinglevelsofirisininmiddleagedfirstdegreerelativesoftype2diabetesmellituscorrelationwithpancreaticbcellfunction AT xiexinmiao circulatinglevelsofirisininmiddleagedfirstdegreerelativesoftype2diabetesmellituscorrelationwithpancreaticbcellfunction AT gaoting circulatinglevelsofirisininmiddleagedfirstdegreerelativesoftype2diabetesmellituscorrelationwithpancreaticbcellfunction AT yanglili circulatinglevelsofirisininmiddleagedfirstdegreerelativesoftype2diabetesmellituscorrelationwithpancreaticbcellfunction AT yuxuemei circulatinglevelsofirisininmiddleagedfirstdegreerelativesoftype2diabetesmellituscorrelationwithpancreaticbcellfunction |